- cafead   Oct 25, 2022 at 11:42: PM
via Vas Narasimhan is steadfast on his mission to reshape Novartis, culling a few programs last quarter and making the final arrangements to spin off generics unit Sandoz. But make no mistake — he’s also “willing to be patient.”
article source
article source